...
logo of 12th Annual Symposium on Antiviral Drug Resistance
link to welcome page on 12th Annual Symposium on Antiviral Drug Resistance website link to general information page on 12th Annual Symposium on Antiviral Drug Resistance website link to registration page on 12th Annual Symposium on Antiviral Drug Resistance website link to abstract submission page on 12th Annual Symposium on Antiviral Drug Resistance website link to important dates page on 12th Annual Symposium on Antiviral Drug Resistance website link to invited speakers page on 12th Annual Symposium on Antiviral Drug Resistance website link to scientific program page on 12th Annual Symposium on Antiviral Drug Resistance website link to participation support page on 12th Annual Symposium on Antiviral Drug Resistance website link to sponsors page on 12th Annual Symposium on Antiviral Drug Resistance website link to contact page on 12th Annual Symposium on Antiviral Drug Resistance website link to home page on 12th Annual Symposium on Antiviral Drug Resistance website
program banner for 12th Annual Symposium on Antiviral Drug Resistance website

In the schedule below, click on a session title to go to that particular session.  Keynote talks are designated with an asterisk.  Abstracts of the talks and posters have been posted here beginning November 6, 2011.

SUNDAY, NOV 6 6:00-7:35 pm Oral Session 1:
Introduction and Overviews
MONDAY, NOV 7 9:00-10:20 am Oral Session 2:
Viral Entry

.
10:50 am-3:10 pm Oral Session 3:
Nucleic Acid Replication

.
3:40-6:00 pm Oral Session 4:
Host Factors in Viral Replication

.
6:00-7:30 pm Poster Session 1
TUESDAY, NOV 8 9:00-11:50 am Oral Session 5:
Biology of Viral Infection

.
1:00-3:00 pm Oral Session 6:
Novel Antiviral Strategies

.
3:30-4:50 pm Oral Session 7:
Microbicides and Other Preventive Strategies

.
5:00-6:30 pm Poster Session 2
WEDNESDAY, NOV 9 8:30 am-12:30 pm Oral Session 8:
Assembly, Release, and Processing



SUNDAY, NOVEMBER 6

Session 1:  Introduction and Overviews
Session 1:  (Chair, John Coffin)

John Coffin
Welcoming Remarks

* Raymond Schinazi
The Drug Development Process: The Case of Hepatitis C Virus (Abstract)

* Charles Bangham
HTLV-1 Persistence in Vivo: Clonality, Dynamics and Immune Response (Abstract)


MONDAY, NOVEMBER 7

Session 2:  Viral Entry
Session 2:  (Chair, Jonathan Stoye)

* Billy Tsai
How the Non-Enveloped SV40 Penetrates the ER Membrane during Entry (Abstract)

* Walther Mothes
Cell-to-Cell Transmission Can Overcome Multiple Barriers Imposed on Cell-Free HIV (Abstract)

Javier G. Magadán
Transmembrane Domain Determinants of CD4 Downregulation by HIV-1 Vpu (Abstract)

Session 3:  Nucleic Acid Replication
Session 3:  (Co-Chairs, Kenneth Johnson and Harriet Isom)

* Timothy Tellinghuisen
The Hepatitis C Virus NS5A Protein: Emerging Roles in Replication, Assembly, and Regulation Define a Potent Antiviral Target (Abstract)


Katarzyna Purzycka
Making Sense of Antisense: Exploring RNA Structure within TY1 Virus-Like Particles (Abstract)


Kalyan Das
Crystal Structure of HIV-1 Reverse Transcriptase in Complex with dsDNA and Nevirapine Reveals Non-Nucleoside Inhibitor Mechanism (Abstract)


Wei Yang
Novel Insights from the High Resolution Structure of HIV-1 RT Containing a Nonnucleoside Inhibitor and an RNA/DNA Hybrid (Abstract)


Atsuko Hachiya
HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Nonnucleoside RT Inhibitors (Abstract)


Daouda Abba-Moussa
Structural Dynamic of HIV-1 Reverse Transcriptase as a New Target to Block HIV Replication (Abstract)

* Peter Cherepanov
The Mechanism of HIV Integration and Its Inhibition by Strand Transfer Inhibitors: Lessons from X-ray Crystallography Studies Using a Convenient Model System (Abstract)

Kasthuraiah Maddali
Dihydroxy-oxoisoindoline Derivatives That Target Raltegravir-Resistant HIV-1 Integrase: A Novel Approach against HIV/AIDS (Abstract)

Barry Johnson
Applying MD Simulations to an HIV-1 Integrase Model (Abstract)

Session 4:  Host Factors in Viral Replication
Session 4:  (Chair, Henry Levin)

* Jeremy Luban
TRIM5 Is an Innate Immune Sensor for the Capsid of HIV-1 and Other Retroviruses (Abstract)

* Monsef Benkirane
How SAMHD1 May Change Our View of Viral Restriction (Abstract)

Jonathan Stoye
Structure and Function of the HIV Restriction Factor SAMHD1 (Abstract)

KyeongEun Lee
Interplay between CPSF6 and TNPO3 Regulates HIV-1 Early Infection (Abstract)

Leslie Parent
CRM1 and the Viral RNA Packaging Element Promote Plasma Membrane Localization of the Rous Sarcoma Virus Gag Protein (Abstract)

Xiaofei Jia
Structural Basis of HIV-1 Nef-Mediated Downregulation of MHC-I (Abstract)

Poster Session 1


TUESDAY, NOVEMBER 8

Session 5:  Biology of Viral Infection
Session 5:  (Chair, Jeffrey Lifson)

* Marco Salemi
Phylogeography of Human Infectious Diseases (Abstract)

Dara Lehman
Low-Frequency Nevirapine Resistance at Multiple Sites May Predict Treatment Failure in Infants on Nevirapine-Based Treatment (Abstract)

Gisela Heidecker
Evolution of the Primate APOBEC3 Locus (Abstract)

* Eric Delwart
Drinking from the Metagenomic Fire Hose: Viral Discovery through Sequence Homology (Abstract)

Krista Delviks-Frankenberry
The Genesis of XMRV through Recombination (Abstract)

Mary Kearney
Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection (Abstract)

Session 6:  Novel Antiviral Strategies
Session 6:  (Chair, Ronald Swanstrom)

* Robert Siliciano
A Quantitative Basis for HAART (Abstract)

Lori Emert-Sedlak
Identification of Small Molecule Inhibitors of HIV-1 Nef Function via Src-Family Kinase Coupling in Vitro Identifies a Novel Inhibitor of HIV-1 and SIV Replication (Abstract)

Marc Potempa
Processing Site Context Contributes to Determining the Rate of HIV-1 Protease-Mediated Processing of Gag (Abstract)

Kayoko Waki
A Tale of Two HIV-1 Maturation Inhibitors — Bevirimat (BVM) and PF-46396: Insights into Gag Assembly and Virion Maturation (Abstract)

* Paula Cannon
Designer Nucleases as Antiviral Therapies (Abstract)

Session 7:  Microbicides and Other Preventive Strategies
Session 7:  (Chair, Brandon Keele)

* Ian McGowan
Antiretrovirals for HIV Prevention (Abstract)

Mayla Hsu
The Selection of MIV-150 Resistance-Associated Mutations in SHIV-RT-Infected Rhesus Macaques (Abstract)

* Walid Heneine
Monkey Models of Antiretroviral Prophylaxis for HIV Prevention (Abstract)

Poster Session 2


WEDNESDAY, NOVEMBER 9

Session 8:  Assembly, Release, and Processing
Session 8:  (Chair, Rebecca Craven)

* Michael Malim
Using Rodent Cells to Study HIV-1 Assembly (Abstract)

Olga Nikolaitchik
Regulation of HIV-1 RNA Packaging (Abstract)

* Angela Gronenborn
Structures of Vpr and Vpx in DDB1-DCAF1 Complexes — Unique Surfaces for Substrate Recruitment (Abstract)

* Akira Ono
Localization of HIV-1 Gag to the Plasma Membrane and Its Subdomain (Abstract)

Alan Rein
HIV-1 and MLV Particle Assembly: There Are Many Ways to Get Together (Abstract)

Lichun Li
A Phase Diagram Describing the Mechanism of HBV Core Protein Assembly Effectors (Abstract)

* Bogdan Dragnea
Templated Assembly and Photothermal Imaging of HIV-1 Gag Virus-Like Particles (Abstract)

* Owen Pornillos
Structural and Biochemical Analyses of HIV-1 Capsid Assembly and Maturation (Abstract)

Stephen Hughes
Closing Remarks






Home
Welcome | General Information | Registration | Abstract Submission | Important Dates
Invited Speakers | Scientific Program | Participation Support | Sponsors | Contact

...